Prime Medicine Inc. Revenue 2020–2025
Prime Medicine Inc. annual/quarterly revenue history and growth rate from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Prime Medicine Inc. revenue for the quarter ending September 30, 2025 was 1.2 M, a 486.12% increase year-over-year.
- Prime Medicine Inc. revenue for the twelve months ending September 30, 2025 was 4.0 M, a 577.33% increase year-over-year.
- Prime Medicine Inc. annual revenue for 2025 was 4.6 M, a 55.28% increase from 2024.
- Prime Medicine Inc. annual revenue for 2024 was 3.0 M.
- Prime Medicine Inc. annual revenue for 2023 was 0.
- Prime Medicine Inc. annual revenue for 2022 was 0.
Prime Medicine Inc. (PRME) — Frequently Asked Questions
Prime Medicine Inc. (PRME) is a publicly traded US company. It has a market capitalization of $403M. In fiscal 2025 it reported revenue of $5M and net income of -$201M. Explore PRME's stock price, financial statements, earnings history, margins and key ratios below.
What is Prime Medicine Inc.'s market cap?
Prime Medicine Inc. (PRME) has a market capitalization of $403M.
What is the PRME stock price?
PRME trades at $2.71 (-5.90% on the day).
How much revenue does Prime Medicine Inc. make?
Prime Medicine Inc. reported revenue of $5M in fiscal 2025.
Is PRME profitable?
In fiscal 2025, Prime Medicine Inc. reported net income of -$201M.